Alzheimer’s Research UK receives £3.1 MILLION from Omaze Mallorca Superdraw
Cambridge-based charity, Alzheimer’s Research UK, is celebrating its successful six-week campaign with fundraising platform, Omaze, as the charity receives £3,100,000 from the Mallorca Superdraw.
Cambridgeshire charity, Alzheimer's Research UK, selected as Omaze's next Million Pound House Draw
One lucky person is guaranteed to win a £3 million luxury holiday home, plus £250,000 cash, as part of a new prize draw raising vital funds for Alzheimer’s Research UK.
Record year for Alzheimer’s Research UK as it achieves £50m income milestone during groundbreaking year
Alzheimer’s Research UK’s income has reached £50m for the first time, during a year marked by historic breakthroughs in dementia research.
Alzheimer’s Research UK celebrates ‘Best Companies’ award
Cambridgeshire-based charity, Alzheimer's Research UK, has again been recognised as one of the Best Companies to work for in the East of England.
Alzheimer’s Research UK is new headline charity partner for TTP Cambridge Half Marathon
Alzheimer’s Research UK has been announced as the new headline charity partner for the TTP Cambridge Half Marathon.
Major Mick’s Tintanic completes epic fundraising journey for Alzheimer’s Research UK
Retired Scots Dragoon Guards Major Michael Stanley, better known as Major Mick, has been taking his Tintanic II homemade tin boat on a tour of waterways around the UK this summer.
Major Mick’s 'Tintanic II' sails in to Cambridge for Alzheimer’s Research UK
After his hugely successful adventure with Tintanic – a homemade boat made of tin – in the first lockdown last year, retired Scots Dragoon Guards Major Michael Stanley, better known as Major Mick, has taken his new and “improved” Tintanic II on the road for a tour of waterways around the UK.
The Rainwater Charitable Foundation announces partnership with Alborada Drug Discovery Institute
The Rainwater Charitable Foundation (RCF), one of the largest independent funders of neurodegenerative disease research, today announced that it has entered into a strategic collaborative partnership with the ALBORADA Drug Discovery Institute (ADDI) funded by Alzheimer’s Research UK (ARUK) at the University of Cambridge.